Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | NPC1 | O15118 | 2/20 | 0.58 |
| ▸ | RAB9A | P51151 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | MAOB | P27338 | 8/20 | 0.54 |
| ▸ | MAOA | P21397 | 1/20 | 0.54 |
| ▸ | RELA | Q04206 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | EGFR | P00533 | 1/20 | 0.51 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | CASP7 | P55210 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.48 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12010094 | 1.00 | KMT2A (0.58) | KMT2ANPC1RAB9AMAPTMAOB | |
| SCHEMBL10037013 | 0.85 | KMT2A (0.59) | KMT2AMAPTMAOBRELAKDM4E | |
| SCHEMBL689212 | 0.85 | KMT2A (0.59) | KMT2AMAPTMAOBRELAKDM4E | |
| SCHEMBL29555131 | 0.85 | KMT2A (0.59) | KMT2AMAPTMAOBRELAKDM4E | |
| SCHEMBL20024204 | 0.83 | LMNA (0.56) | KMT2ANPC1RAB9AMAPTALDH1A1 | |
| SCHEMBL17576048 | 0.83 | LMNA (0.56) | KMT2ANPC1RAB9AMAPTALDH1A1 | |
| SCHEMBL20031124 | 0.82 | CA12 (0.57) | KMT2ARAB9AMAPTMAOBRELA | |
| SCHEMBL14588238 | 0.82 | MAOB (0.72) | KMT2ANPC1RAB9AMAPTMAOB | |
| SCHEMBL31109263 | 0.80 | CA12 (0.58) | KMT2ANPC1RAB9AMAPTMAOB | |
| SCHEMBL1959915 | 0.80 | CA12 (0.71) | KMT2ANPC1RAB9AMAPTMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180200170-A1 | SUNSCREEN FORMULATIONS OPTIMIZED FOR THE FORMATION OF VITAMIN D | UV-TECHNIK (DE) | 2018-07-19 | — | — | US | disclosed |
| US-20160067158-A1 | AGENTS CONTAINING LARGE QUANTITIES OF UV STABILIZERS | BASF SE (DE) | 2016-03-10 | — | — | US | disclosed |
| CN-101808976-B | Ultraviolet absorber | LEAD CHEM CO LTD | 2013-03-20 | — | — | CN | disclosed |
| US-8252273-B2 | Ultraviolet absorber | LEAD CHEMICAL CO., LTD. (JP) | 2012-08-28 | — | — | US | disclosed |
| EP-2192106-B1 | ULTRAVIOLET ABSORBER | LEAD CHEM CO LTD (JP) | 2012-02-29 | — | — | EP | disclosed |
| US-20100239508-A1 | ULTRAVIOLET ABSORBER | LEAD CHEMICAL CO., LTD. (JP) | 2010-09-23 | — | — | US | disclosed |
| CN-101808976-A | ultraviolet absorber | LEAD CHEM CO LTD | 2010-08-18 | — | — | CN | disclosed |
| EP-2192106-A1 | ULTRAVIOLET ABSORBER | Lead Chemical Co. Ltd. (JP) | 2010-06-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160067158-A1 | AGENTS CONTAINING LARGE QUANTITIES OF UV STABILIZERS | ERCC5, ERCC1, TTPA | KMT2A 3804/4885NPC1 962/4885RAB9A 2642/4885 |
| US-20100239508-A1 | ULTRAVIOLET ABSORBER | UNG, UACA, ABCG2 | KMT2A 4596/4885NPC1 2126/4885RAB9A 2817/4885 |
| US-20180200170-A1 | SUNSCREEN FORMULATIONS OPTIMIZED FOR THE FORMATION OF VITAMIN D | VDR, CYP2R1, CYP24A1 | KMT2A 4636/4885NPC1 4527/4885RAB9A 2467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.